Get the Stockscreener App
5.58
0.72%
0.04
After Hours:
5.61
0.03
+0.54%
Atai Life Sciences N V stock is traded at $5.58, with a volume of 3.88M.
It is up +0.72% in the last 24 hours and up +23.45% over the past month.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
See More
Previous Close:
$5.54
Open:
$5.57
24h Volume:
3.88M
Relative Volume:
0.67
Market Cap:
$1.20B
Revenue:
$2.59M
Net Income/Loss:
$-137.89M
P/E Ratio:
-6.8889
EPS:
-0.81
Net Cash Flow:
$-69.76M
1W Performance:
+7.31%
1M Performance:
+23.45%
6M Performance:
+361.16%
1Y Performance:
+393.81%
1-Day Range:
$5.38
$5.6132
1-Week Range:
$4.9922
$5.69
52-Week Range:
$1.03
$5.965
Atai Life Sciences N V Stock (ATAI) Company Profile
Name
Atai Life Sciences N V
Sector
Industry
Phone
49 89 2153 9035
Address
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Compare ATAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATAI
Atai Life Sciences N V
|
5.58 | 1.30B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-25 | Initiated | Oppenheimer | Outperform |
| Nov-18-24 | Reiterated | H.C. Wainwright | Buy |
| Apr-03-24 | Upgrade | Maxim Group | Hold → Buy |
| Nov-01-22 | Initiated | Loop Capital | Buy |
| Nov-30-21 | Initiated | Maxim Group | Buy |
| Nov-11-21 | Initiated | ROTH Capital | Buy |
| Oct-18-21 | Initiated | H.C. Wainwright | Buy |
| Sep-01-21 | Initiated | Jefferies | Buy |
| Jul-13-21 | Initiated | Berenberg | Buy |
| Jul-13-21 | Initiated | Canaccord Genuity | Buy |
| Jul-13-21 | Initiated | Cantor Fitzgerald | Buy |
| Jul-13-21 | Initiated | Citigroup | Buy |
| Jul-13-21 | Initiated | Cowen | Outperform |
| Jul-13-21 | Initiated | Credit Suisse | Outperform |
| Jul-13-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-08-21 | Initiated | Aegis Capital | Buy |
View All
Atai Life Sciences N V Stock (ATAI) Latest News
Evaluating Atai Life Sciences N.V. with trendline analysis2025 Market Overview & Fast Moving Stock Trade Plans - newser.com
What sentiment indicators say about Atai Life Sciences N.V. stockJuly 2025 Volume & Expert Approved Momentum Ideas - newser.com
Will Atai Life Sciences N.V. stock outperform growth indexes2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Quantitative breakdown of Atai Life Sciences N.V. recent moveJuly 2025 Volume & Stepwise Swing Trade Plans - newser.com
Can trapped investors hope for a rebound in Atai Life Sciences N.V.Bear Alert & AI Powered Buy and Sell Recommendations - newser.com
How Atai Life Sciences N.V. (9VC) stock responds to job market shifts2025 Price Targets & Expert Curated Trade Setup Alerts - newser.com
How to track smart money flows in Atai Life Sciences N.V.IPO Watch & Weekly Watchlist for Hot Stocks - newser.com
Using RSI to spot recovery in Atai Life Sciences N.V.July 2025 Intraday Action & Expert Verified Movement Alerts - newser.com
Short interest data insights for Atai Life Sciences N.V.2025 Growth vs Value & AI Powered Market Entry Strategies - newser.com
Momentum divergence signals in Atai Life Sciences N.V. chartPortfolio Growth Summary & Risk Managed Investment Signals - newser.com
Why Atai Life Sciences (ATAI) Is in Focus After Positive Depression Data and $239M Shelf Registration Filing - Yahoo Finance
What drives Atai Life Sciences NV stock priceMonthly Performance Summary & High Profit Trading Plans - earlytimes.in
Atai Life Sciences: Still A Decent ProspectBut Only Just (NASDAQ:ATAI) - Seeking Alpha
Atai Life Sciences files to sell 45.32M common shares by selling shareholders - MSN
ATAI Life Sciences files additional details on Beckley Psytech acquisition By Investing.com - Investing.com Australia
ATAI Life Sciences files additional details on Beckley Psytech acquisition - Investing.com India
ATAI Life Sciences to Acquire Beckley Psytech Shares - TipRanks
Published on: 2025-09-29 01:36:53 - earlytimes.in
What analysts say about Atai Life Sciences NV stockFundamental Strength Indicators & Exceptional Growth Portfolio - earlytimes.in
Atai Life Sciences NV Stock Analysis and ForecastHigh Frequency Trading Trends & Smarter Trades Backed by Machine Learning - earlytimes.in
Is Atai Life Sciences NV 9VC a good long term investmentDay Trading Setups & Connect With Bulls, Avoid the Bears - Early Times
ATAI Life Sciences NV Hits New 52-Week High of $5.96 - Markets Mojo
ATAI Life Sciences Hits Day High with 14.96% Surge in Stock Price - Markets Mojo
ATAI Life Sciences NV Hits New 52-Week High of $5.76 - Markets Mojo
Canaccord Genuity reaffirms Buy rating on atai Life Sciences stock - Investing.com
atai Life Sciences stock rating reiterated at Buy by H.C. Wainwright - Investing.com Canada
Canaccord Genuity reaffirms Buy rating on atai Life Sciences stock By Investing.com - Investing.com Canada
atai and Beckley’s psychedelic advances to pivotal TRD trial - Yahoo Finance
Atai Life Sciences N V Stock (ATAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.05%
4.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):